Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB01201_DB06772_nanopub.RAp-Y7hV7AADhM91FrXWC575krwZmZ_3Vs0dgVluLbASo#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB01201_DB06772 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB01201_DB06772 label "DDI between Rifapentine and Cabazitaxel - Concomitant therapy with a strong CYP3A inducer may decrease concentrations of cabazitaxel. Avoid concomitant therapy. [drugbank_resource:DB01201_DB06772]" assertion.
- drugbank_resource:DB01201_DB06772 identifier "drugbank_resource:DB01201_DB06772" assertion.
- drugbank_resource:DB01201_DB06772 title "DDI between Rifapentine and Cabazitaxel - Concomitant therapy with a strong CYP3A inducer may decrease concentrations of cabazitaxel. Avoid concomitant therapy." assertion.
- drugbank:DB01201 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB01201_DB06772 assertion.
- drugbank:DB06772 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB01201_DB06772 assertion.